Professional Activities - Luis A. Ortiz

Invited Lectures (past 5 years) Modulation of bleomycin induced lung injury by bone marrow derived mesenchymal stem cells American Physiological Society. Annual meeting experimental biology FASEB 2009. New Orleans, LA, 2009. Novel treatments for pulmonary fibrosis: Stem cells and all the Jazz. American Thoracic Society. San Diego, California. May, 2009. S1P receptors mediate mesenchymal stem cells (MSCs) migration. American Thoracic Society. San Diego, California. May, 2009. TNF protects macrophages from silica induced apoptosis. Society of Toxicology. Salt Lake City, Utha. February 2010. The role of stem cells in the pathogenesis and treatment of silicosis;. Division Pulmonary Medicine Tulane Health Science Center. New Orleans, Louisiana. May 2010. Regulation of the Innate Immunity by Bone Marrow Derived Mesenchyma as Potential Treatment for Environmentally Induced Lung Injury. Division Pulmonary Medicine University of Iowa. Iowa City, Iowa. September 2010. Regulation of macrophage biology by mesenchymal stem cells (MSC) involve mitochondrial transfer. 16th International Colloquium on Lung and Airway Fibrosis. Busselton, Western Australia, Australia, October 2010. Mesenchymal stem cell secretome in pulmonary fibrosis. Division of Pulmonary, Critical Care, and Environmental Medicine at the University of Rochester. Rochester, New York. December 2010. Mesenchymal stem cell secretome: mitochondrial transfer and microRNA shuttle. Institute for Regenerative Medicine at Texas A&M Health Science Center at Scott & White, Temple, Texas. March 2011. Mesenchymal Stem Cells Postgraduae course (PG27) Functional analysis of stem cells: getting ready to translate. American Thoracic Society. Denver, Colorado. May 2011. Mesenchymal stem cell transfer of mitochondria via the secretome Featured speaker of the mini symposium (B18) Mitochondrial function in pulmonary health and disease. American Thoracic Society. Denver, Colorado. May 2011. The mesenchymal stem cell (MSC) secretome involves mitochondrial transfer. American Thoracic Society. Denver, Colorado. May 2011. “Effects of mesenchymal stem cell (MSC) transfer of micro RNA’s and mitochondria as mechanisms of immune regulation in models of lung fibrosis”.  Hospital Clinic de la Universidad de Barcelona.  Barcelona, Spain.  September 2011 “Mesenchymal Stem Cells use their exosome to transfer mitochondrial and micro RNAs, and promote homeostasis during fibrotic lung injury” Comprehensive Pneumology Center  Ludwig-Maximilians-Universität.  Munich, Germany.  October 2011 “Use of bone marrow mesenchyme to reprogram lung immunity in response to inhalation injuries”.  Center for Vaccine Research At the University of Pittsburgh.  Aerobiology Mini-Symposium.  Pittsburgh, Pennsylvania.  November 2011 “The use of Bone Marrow Derived Mesenchyme to reprogram Lung Immunity in response to inhalation injuries”.  Institute for environmental medicine.  Perelman School of Medicine at the University of Pennsylvania.  Philadelphia, Pennsylvania.  January 2012 “Mesenchymal Stem Cells Utilize the Secretome to Reprogram Innate Immunity and Ameliorate Silica-Induced Lung Injury”.  Department of Environmental Health, Molecular and Integrative Physiological Sciences.  Harvard School of Public Health.  Boston, Massachusetts.  March, 2012 “The use of Mesenchymal Stem Cells and their secretome in the treatment of Lung Fibrosis”.  Department of Medicine at the Medical College of Wisconsin.  Milwaukee, Wisconsin. May, 2012 “Mesenchymal Stem Cells (MSC) use their secretome to Outsource mitophagy and reprogram innate immunity”. Department of Medicine at the University of California San Diego.  San Diego, California.  June 2012 “The Use of Mesenchymal Stem Cell Secretorme (mitochondrial transfer and micro RNA shuttle) to Treat Pulmonary Fibrosis.  Division of Pulmonary, Allergy and Critical Care at Duke University.  Raleigh-Durham, North Carolina.  August 2012 “micro RNA in mesenchymal stem cells derived exosomes ameliorate pulmonary fibrosis”  The 17th Interantional Colloquium on Lung and Airway Fibrosis.  Modena, Italy.  October 2012 “Mesenchymal Stem Cells and Lung Fibrosis”. NHLBI-Division of Lung Disease: Cell Therapy of Lung Diseases Workshop.  Rockledge, Maryland.  November 2012 “Macrophage mediated inflammation in pulmonary fibrosis”. NHLBI-Division of Lung Disease: IPF Workshop.  Rockledge, Maryland.  November 2012 “Mesenchymal stem cells transfer mitochondria and micro RNAs to modulate macrophages in lung fibrosis”.  5th LACI satellite Meeting in Immunology.  EMBO Workshop program:  Dr. Jekyll and Mr Hyde:  The Macrophage in inflammation and immunity.  Marseille, France.  January 2013 “Progress on the utilization of bone marrow derived mesenchymal stem cells to treat fibrotic lung injuries”.  Basic and translational research conference.  Division of Pulmonary, Allergy, and Critical Care Medicine at the University of Pittsburgh.  Pittsburgh, Pennsylvania.  March 2013 “Mesenchymal Stem Cells Use Extracellular Vesicles To Transfer Mitochondria And Micro RNAs To Modulate Macrophages In Lung Fibrosis”.  International Society for Extracellular Vesicles.  Boston, Massachusetts.  April 2013 “Mesenchymal Stem Cells Secretome: A New Paradigm In the Treatment of Environmental Lung Injury”.  Environmental Pulmonary Health Research Program: Getting Into Fundamentals.  Sponsored by the National Institute of Environmental Health Sciences/NIH.  American Thoracic Society.  Philadelphia, Pennsylvania.  May 2013 “Harnessing the Mesenchymal Stem Cell Secretome to couple RV and PA Pressure During Lung Fibrosis”.  Center for Regenerative Medicine at Harvard University.  Brigham and Women’s Hospital.  Boston, Massachusetts.  July 2013 Visiting Professorships Division of Pulmonary and Critical Care Medicine University of Texas Health Science Center at Houston Houston, Texas. June, 1995.   Division of Thoracic Surgery University of Rome (La sapienzzia) Rome, Italy. November, 1995.   Department of Pathology Istituto de Patologia Generale de la Universidad de Siena Siena, Italy. November 1995. Division of Pulmonary and Critical Care Medicine Yale University New Haven, Connecticut. December 2005. Division of Pulmonary and Critical Care Medicine University of California San Francisco San Francisco, CA. November 2008. Division of Pulmonary, Allergy and Critical Care Medicine Duke University: External reviewer of the T32 Training Grant In Pulmonary Medicine Raleigh-Durham, NC.  August 2012. Secondary Appointments Associate Professor Clinical and Translational Science Institute (CTSI) July 1, 2011 - June 30, 2014